Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
62°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Revance Therapeutics
(NQ:
RVNC
)
3.275
-0.045 (-1.36%)
Streaming Delayed Price
Updated: 2:45 PM EDT, May 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Revance Therapeutics
< Previous
1
2
3
4
5
6
Next >
Why Fresh Tracks Therapeutics Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket
September 20, 2023
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 70.2% to $0.8937 in pre-market trading after falling 10% on Tuesday.
Via
Benzinga
The Latest Analyst Ratings for Revance Therapeutics
September 20, 2023
Via
Benzinga
Instacart, ARS Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
September 20, 2023
U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Dow Falls 150 Points; AutoZone Earnings Top Views
September 19, 2023
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 150 points on Tuesday. The Dow traded down 0.48% to 34,457.36 while the NASDAQ fell 0.28% to 13,672.29. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What's Going On With Botox Rival Revance Therapeutics' Stock Today?
September 19, 2023
Revance Therapeutics Inc (NASDAQ: RVNC) commenced a plan to exit the
Via
Benzinga
Where Revance Therapeutics Stands With Analysts
August 09, 2023
Via
Benzinga
Earnings Preview: Revance Therapeutics
August 07, 2023
Via
Benzinga
What 5 Analyst Ratings Have To Say About Revance Therapeutics
July 11, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 19, 2023
During Tuesday's session, 275 companies made new 52-week lows.
Via
Benzinga
Why Terran Orbital Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 19, 2023
Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday.
Via
Benzinga
Crude Oil Rises Over 1%; Revance Therapeutics Shares Plummet
September 19, 2023
U.S. stocks traded lower midway through trading, with the Dow Jones falling more than 200 points on Tuesday. The Dow traded down 0.69% to 34,384.29 while the NASDAQ fell 0.82% to 13,597.78. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Former IBD 50 Stock Revance Implodes As Its 'Prestige' Plan Goes Up In Smoke
September 19, 2023
The company is still figuring out how to gain share in a market topped by AbbVie.
Via
Investor's Business Daily
Markets Open Lower; US Housing Starts Fall In August
September 19, 2023
U.S. stocks traded lower this morning, with the Dow Jones falling around 40 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.12% to 34,581.70 while the NASDAQ fell 0.33%...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
3 Healthcare Stocks to Sell in September Before They Crash & Burn
September 06, 2023
The prognosis for these healthcare stocks isn't optimistic so plan to sell them this month before they get worse.
Via
InvestorPlace
3 Very Oversold Biotech Stocks to Buy Right Now
August 29, 2023
These biotech stocks have tumbled a great deal in recent months, but their long-term outlooks remain quite strong.
Via
InvestorPlace
Analyst Expectations for Revance Therapeutics's Future
June 07, 2023
Via
Benzinga
Earnings Preview For Revance Therapeutics
May 08, 2023
Via
Benzinga
7 Analysts Have This to Say About Revance Therapeutics
April 11, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About Revance Therapeutics
January 24, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
September 11, 2023
Monday's session saw 175 companies set new 52-week lows.
Via
Benzinga
3 Very Oversold Pharma Stocks to Buy Right Now
August 24, 2023
Oversold pharma stocks have great total return potential. In this article, we list some of the best to buy.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2023
August 16, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
September 08, 2023
Friday's session saw 225 companies set new 52-week lows.
Via
Benzinga
How Revance Is Taking A Page Out Of AbbVie's Botox Playbook
August 14, 2023
The company sells a cosmetic treatment. Now, it's bridging into neuroscience.
Via
Investor's Business Daily
Stocks That Hit 52-Week Lows On Thursday
September 07, 2023
On Thursday, 283 companies set new 52-week lows.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
July 12, 2023
Via
Benzinga
7 Healthcare Stocks to Make You the Millionaire Next Door
June 21, 2023
For investors who want to greatly increase their wealth in the long term, these are the best healthcare stocks to buy.
Via
InvestorPlace
7 Stocks to Buy for the Massive Rally Ahead
April 04, 2023
With economic growth poised to exceed expectations in 2023, here are seven stocks to buy for a market rally.
Via
InvestorPlace
3 Pharma Stocks That Will Mint Millionaires
January 30, 2023
These pharma stocks all have excellent risk-reward ratios and the companies have developed treatments that could easily become blockbusters.
Via
InvestorPlace
Earnings Scheduled For February 28, 2023
February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.